Does L-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials

Farzaneh Pirmadah, Nahid Ramezani-Jolfaie, Mohammad Mohammadi, Nasir Talenezhad, Cain Clark, Amin Salehi-Abargouei

Research output: Contribution to journalReview article

1 Downloads (Pure)

Abstract

Background and aims: l-carnitine supplementation is proposed to reduce liver enzymes levels; however, previous findings were equivocal. The current systematic review and meta-analysis of randomized controlled clinical trials (RCTs) were performed to assess the effect of l-carnitine supplementation on serum levels of enzymes mainly produced by liver [alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transpeptidase (GGTP)]. Methods: Online databases as well as the reference lists of relevant studies were searched from inception up to June 2019. The risk of bias in individual studies was assessed using Cochrane Collaboration’s tool. Data were pooled using the random-effects model and expressed as mean differences (MDs) with 95% confidence intervals (CIs). Results: In total, 18 RCTs (1161 participants) met the eligibility criteria. l-carnitine supplementation dose ranged from 500 to 4000 mg/day. l-carnitine supplementation significantly reduced serum ALT (MD = − 8.65 IU/L, 95% CI − 13.40, − 3.90), AST (MD = − 8.52 IU/L, 95% CI − 12.16, − 4.89), and GGTP (MD = − 8.80 IU/L, 95% CI − 13.67, − 3.92) levels. The subgroup analysis showed that l-carnitine might be more effective in reducing the enzymes when supplemented in higher doses (≥ 2000 mg/day), for longer durations (> 12 weeks), and among patients with liver diseases. The meta-evidence was graded as “moderate” for ALT and AST, and “low” for GGTP according to NutriGrade scoring system. Conclusion: l-carnitine supplementation significantly improves circulating ALT, AST and GGTP levels; therefore, it might positively affect liver function, especially among patients with liver diseases. Further high-quality RCTs are recommended to confirm our results.

Original languageEnglish
Pages (from-to)1767–1783
Number of pages17
JournalEuropean Journal of Clinical Nutrition
Volume59
Issue number5
Early online date5 Aug 2019
DOIs
Publication statusPublished - Aug 2020

Bibliographical note

The final publication is available at Springer via http://dx.doi.org/10.1007/s00394-019-02068-4


Copyright © and Moral Rights are retained by the author(s) and/ or other copyright owners. A copy can be downloaded for personal non-commercial research or study, without prior permission or charge. This item cannot be reproduced or quoted extensively from without first obtaining permission in writing from the copyright holder(s). The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the copyright holders.

Keywords

  • Alanine aminotransferase (ALT)
  • Aspartate aminotransferase (AST)
  • Meta-analysis
  • Systematic review
  • l-carnitine

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Nutrition and Dietetics

Fingerprint Dive into the research topics of 'Does L-carnitine supplementation affect serum levels of enzymes mainly produced by liver? A systematic review and meta-analysis of randomized controlled clinical trials'. Together they form a unique fingerprint.

  • Cite this